The roles of topoisomerases I and II in Epstein-Barr virus (EBV) replication were investigated using Raji cells infected with EBV. The topoisomerase II inhibitor ellipticine inhibited the synthesis of EBV polypeptides at concentrations which did not affect total protein synthesis. Slot blot analysis of total cellular DNA showed that camptothecin and ellipticine inhibited replication of progeny EBV DNA in superinfected Raji cells at concentrations which did not inhibit synthesis of EBV early polypeptides prerequisite for EBV DNA replication. Analysis of the structure of EBV DNA termini demonstrated that both inhibitors affected the replicating EBV DNA. Gardella gel electrophoresis showed that both inhibitors affected the formation of the linear form of EBV DNA. However, restriction analysis of EBV DNA in superinfected Raji cells demonstrated that both inhibitors degraded neither endogenous nor exogenous EBV DNA. Cell viability was not affected by either inhibitor at the concentrations tested. These findings suggest that topoisomerase II is required for expression of the EBV genome and that both topoisomerases I and II are involved in replication of the EBV genome during the lytic phase of the life cycle. The effects of topoisomerase inhibitors on the circular form of EBV DNA during virus replication are discussed.
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Topoisomerases I and II are involved in gene expression and replication of eukaryotes (Maxwell & Gellert, 1985; Wang, 1985) . In the case of animal viruses, topoisomerases play important roles in viral DNA replication, transcription, packaging and integration (Foglesong & Bauer, 1984; Snapka, 1986; Nishiyama et al., 1987; Benson & Huang, 1988; Champoux, 1988; Richter & Strausfeld, 1988; Ebert et al., 1990; Priel et al., 1990 Priel et al., , 1991 Schaack et al., 1990a, b; Wong & Hsu, 1990; Yamada et al., 1990; Gu & Rhode, 1991; Priel et al., 1991 ; Wang & Rogler, 1991) . Topoisomerase I changes the linking numbers of topological DNA domains in integral steps of one by introducing transient singlestrand breaks. Topoisomerase II breaks both DNA strands and resolves them, thereby changing topological linking numbers in steps of two.
Recently, several specific inhibitors for mammalian DNA topoisomerases have been identified and characterized (Drlica & Franco, 1988) . Camptothecin and ellipticine are specific inhibitors of mammalian topoisomerases I and II, respectively (Tewey et al., 1984; Hsiang et al., 1985) . Camptothecin stablizes the covalent topoisomerase I-DNA complex, resulting in blockage of the rejoining step of the breakage-reunion reaction of topoisomerase I. Ellipticine affects the breakage-reunion reaction of topoisomerase II by stablizing the cleavable complex formed between topoisomerase II and DNA.
These inhibitors are suitable for studying the functional involvement of topoisomerase activities in Epstein-Barr virus (EBV) gene expression and replication. EBV early antigen (EA) synthesis is induced in Raji cells by infection with P3HR-1 virus, followed by viral DNA replication and EBV late antigen synthesis. In this study, the effects of camptothecin and ellipticine on EBV replication were analysed using this cell system. Cells were grown in RPMI-1640 medium supplemented with 10 % fetal calf serum, penicillin (100 units/ ml) and streptomycin (250 gg/ml). P3HR-1 virus was obtained from culture fluid of a P3HR-1 substrain containing heterogeneous EBV DNA. Raji cells were infected with concentrated P3HR-1 EBV at an m.o.i, of 500. After adsorption at 37 °C for 1 h, infected cells were cultivated in fresh medium in the presence or absence of camptothecin and ellipticine at the indicated concentrations.
To investigate the effects of camptothecin and ellipticine on EBV gene expression, EBV-induced polypeptides were analysed by the immunoprecipitation method as previously described (Kawanishi et al., 1981) . , and treated with 1 and 2.5 ~tM-camptothecin (lanes 2 and 3, respectively), 2.5 and 5 ~tM-ellipticine (lanes 4 and 5, respectively), or 300 lag/ml PAA (lane 6) were analysed by 10% SDS PAGE.
dividual cell extracts with serum from a nasopharyngeal carcinoma (NPC) patient (anti-EA and -VCA titres are 1:320 and 1:80, respectively) were collected with Protein A-Sepharose, and analysed by 10% SDS-P A G E followed by autoradiography. As shown in Fig. 1 , numerous EBV-specific polypeptides were induced in Raji cells by infection with EBV. Treatment of infected cells with 0"1 and 0.25 gM-camptothecin only slightly inhibited the synthesis of EBV-induced polypeptides ( Fig. 1 a, lanes 2 and 3, respectively). At these concentrations, total protein synthesis was also only slightly affected (data not shown). However, viral and total protein synthesis was drastically inhibited by treatment with 1 laM-camptothecin ( Fig. 1 a, lane 4, and b, lane 2, respectively). As the inhibition pattern of viral protein synthesis was quite similar to that of total protein synthesis, viral and cellular protein synthesis appeared to be equally sensitive to camptothecin. Based on these results, it can not be concluded that topoisomerase I is involved in EBV gene expression. Ellipticine slightly affected only the synthesis of EBV-induced polypeptides with rather high Mr values at a concentration of 2.5 ~tU ( Fig. 1 a, lane 6) . At 5 p i , ellipticine drastically inhibited total viral protein synthesis ( Fig. 1 a, lane 7) without affecting synthesis of cellular proteins ( Fig. 1 b, lane 5) .
The results suggest that viral gene expression may be more highly sensitive to ellipticine than most cellular gene expression and that topoisomerase II plays a more direct role in EBV gene expression. The inhibitory effect of ellipticine on EBV gene expression was considered not to be due to side-effects, because cell viability determined by trypan blue exclusion staining was not affected by 16 h treatment at the concentrations tested (data not shown).
The effects of camptothecin and ellipticine on EBV DNA replication were determined by three independent assays. First, relative amounts of EBV D N A were analysed by the slot blot technique. High M r D N A was purified from the infected cells by the method of Sambrook et al. (1989) . Two gg of DNA was denatured by treating at 100 °C for 5 min in 0.4 M-NaOH and 10 mM-EDTA and transferred to nitrocellulose filters using the Bio-Dot apparatus (Bio-Rad). Filters were hybridized with 3~P-labelled EBV B a m H l W fragments. Scans of the autoradiogram were obtained by using a laser densitometer (LKB 2222 UltroScan XL). As shown in Fig. 2 , there was an approximately 100-fold increase in overall amounts of EBV D N A at 24 h p.i., when compared with those at 4 h p.i. Treatment of infected cells with camptothecin and ellipticine inhibited the amplification of EBV D N A in a dose-dependent manner. Camptothecin (0.1 gU) and ellipticine (2.5 laM) reduced amounts of amplified viral D N A to the same level as those in cells treated with phosphonoacetic acid (PAA) (300 ~tg/ml), a specific inhibitor of EBV-induced D N A polymerase. At these concentrations, camptothecin inhibited neither viral protein synthesis (Fig. 1 a, lane 2) nor total protein synthesis (data not shown), and ellipticine only slightly affected viral protein synthesis (Fig. 1 a, lane 6 ) without affecting total protein synthesis ( Fig. 1 b, lane 4) . Twenty-four hours treatment with both inhibitors did not affect cell viability at the concentrations tested (data not shown). These results indicate that the inhibitory effects of camptothecin and ellipticine on EBV DNA replication are neither due to the suppression of viral protein synthesis required for viral D N A replication nor due to their side-effects.
To examine more directly the effects of topoisomerase inhibitors on replicating EBV DNA, the structure of the EBV genome termini was analysed. EBV DNA has homologous direct repeats of approximately 500 bp at each terminus. The structure of the EBV termini contributes evidence for viral replication, as indicated by the appearance of ladder arrays of terminal fragments representing fused and linear forms of EBV DNA (RaabTraub & Flynn, 1986; Katz et al., 1989) . Total cellular DNA was digested with BamHI, electrophoresed in a 0.6 % agarose gel and transferred to nitrocellulose filters. EBV-specific DNA was probed with the a2P-labelled 1.9 kb XhoI fragment located near the right terminus (Raab-Traub & Flynn, 1986) . As shown in Fig. 3(a) , a 21 kb fragment represented the fused terminus of the episomal form of endogenous EBV DNA in Raji cells (lane 1), and 7 kb and smaller ladder DNA fragments represented the right termini of linear form EBV DNA from exogenous P3HR-1 virus (lane 2). Multiple fused terminal fragments ranging from 9 to 12 kb appeared at 12 h p.i. (lane 4) and increased in density with time after infection (lanes 5 and 7). DNA fragments representing linear termini were also increased in density with time after infection. These fragments were greatly reduced by treatment with PAA (lane 6). These results indicated that fused terminal fragments and increased DNA fragments representing linear termini were replication-dependent forms. As shown in Fig. 3(b) , after treatment with 0.25 gM-camptothecin and 2.5 gM-ellipticine, the amounts of increased ladder fragments representing fused and linear termini were reduced to the same level as those in cells treated with PAA (300 gg/ml). In contrast, the 21 kb fragment representing fused termini of endogenous circular form EBV D N A was not amplified by infection with P3HR-1 virus and was not affected by treatment with either inhibitor. These results suggest that camptothecin and ellipticine affect replicating EBV D N A but not the amount of endogenous EBV DNA. The effect of topoisomerase inhibitors on the formation of linear and circular forms of EBV D N A was analysed by Gardella gel electrophoresis (Gardella et al., 1984) . The Gardella gel technique is suitable for resolution of linear and covalently closed circular DNA. As shown in Fig. 4 Fig. 5 , the 8.6 kb, 4.7 kb and 2-3 kb fragments were detected in P3HR-1 virus-(lane 6) but not in mock-infected Raji cells (lane 5). The results indicate that these fragments are derived from exogenous P3HR-1 virus. Since the 2.0 kb fragment was not detected in P3HR-1 virus DNA, it was considered to be specific for endogenous EBV D N A in Raji cells. The density of the bands of the 8"6 kb, 4.7 kb and 2-3 kb fragments was increased in infected Raji cells These results suggest that both topoisomerases I and II play a role in the replication of EBV DNA by virusassociated DNA polymerase. The role of topoisomerases in DNA replication has been studied in a number of organisms (Maxwell & Geltert, 1985; Wang, 1985) . In the case of viruses, Snapka (1986) has reported that topoisomerase II inhibitors including ellipticine block decatenation of newly replicated simian virus 40 daughter chromosomes and lead to an accumulation of catenated dimers containing single-strand DNA breaks and that camptothecin rapidly breaks the replication fork in growing Cairns structures. Recent reports have shown that the cellular topoisomerase II can induce double-strand breaks at specific locations in herpes simplex virus type 1 DNA and is involved in aspects of viral replication at late times in the infection cycle (Ebert et aL, 1990) . The same mechanisms would occur in EBV DNA replication.
The present study has indicated that mammalian topoisomerases are involved in various steps during the lytic phase of the EBV life cycle. However, it remains to be clarified whether the topoisomerases I and II involved in EBV replication are virus-encoded or cellular in origin. As the topoisomerase II associated with EBV gene expression was shown to be more sensitive to ellipticine than that involved in cellular gene expression, these enzymes might be different in origin. Although topoisomerase II has been shown to be associated with DNA replication of various kinds of herpesviruses (Nishiyama et al., 1987; Benson & Huang, 1988; Ebert et al., 1990) including EBV, this is the first study that demonstrates involvement of topoisomerase I in viral DNA replication among the herpesvirus group.
I am grateful to Professor Yoshifumi Takeda for his encouragement throughout this work.
